Biocon Ltd. — Regulatory Filings 2020

May 21, 2020

==> picture [75 x 30] intentionally omitted <==

Biocon Limited 20th KM, Hosur Road Electronic City Bangalore 560 100, India T 91 80 2808 2808 F 91 80 2852 3423 CIN : L24234KA1978PLC003417 www.biocon.com

Date of submission: May 21, 2020

ToThe SecretaryBSE LimitedDepartment of Corporate ServicesPhiroze Jeejeebhoy Towers,Dalal Street,Mumbai – 400 001	ToThe SecretaryNational Stock Exchange of India LimitedCorporate Communication DepartmentExchange Plaza, Bandra Kurla ComplexMumbai – 400 050
Scrip Code - 532523	Scrip Symbol- BIOCON

Dear Sir/Madam,

Sub: Meetings conducted with Institutional Investors/Research Analysts. Ref: Intimation under Regulation 30 (6) of SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015.

Pursuant to Regulation 30 (6) of the SEBI LODR Regulations, 2015, we hereby inform you that the following meeting were conducted with Institutional Investor / Research Analysts:

Date	List of Participants	Type of meeting	Location
May 21, 2020	Macquarie Investment Management(Asia)	1x1 Teleconference	Bangalore
	Millenium Partners	1x1 Teleconference
	Aberdeen Asset Management Asia	1x1 Teleconference
	Lion Global Investors Limited	1x1 Teleconference
	Allianz Asia	Group Teleconference*
	Fullerton Fund Management
	BNP Paribas Asset Management France
	Bharti AXA Investment Managers
	Mitsubishi UFJ Trust Bank
	Pramerica
	Sumitomo Mitsui
	China Investment Corporation
	Barings LLC
	Citi Research
	PGIM India Mutual Fund
	Value Partners

***** List of participants as received.

We request you to kindly take above intimation on record.

Thanking You,

Yours faithfully,

For Biocon Limited

==> picture [63 x 24] intentionally omitted <==

---

==> picture [50 x 53] intentionally omitted <==

Mayank Verma

Company Secretary and Compliance Officer